Kingstone (KINS) Director Pranav Pasricha Receives 1,536 Shares
Pranav Pasricha, a director of Kingstone Companies, Inc. (KINS), reported acquiring 1,536 shares of the company on 08/19/2025 as payment for director fees.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Pranav Pasricha, a director of Kingstone Companies, Inc. (KINS), reported acquiring 1,536 shares of the company on 08/19/2025 as payment for director fees. The transaction was recorded at a price of $0, and the filing notes these are unvested shares that are scheduled to vest on January 2, 2026, subject to earlier vesting in certain circumstances. The Form 4 was signed by Mr. Pasricha on 08/21/2025. The shares are held in a direct ownership form.
Insights
TL;DR: Routine equity compensation to align director incentives; small, scheduled vesting reduces immediate transferability.
This Form 4 documents a standard practice of compensating board members with restricted stock rather than cash. The 1,536 shares were issued as director fees at $0, indicating a grant rather than an open-market purchase. The noted vesting date of January 2, 2026 means the economic and voting consequences may be limited until vesting conditions are met, lowering immediate dilution or transfer risk. For stakeholders, this is a governance alignment signal but appears immaterial to capital structure given the small share count disclosed.
TL;DR: Non-cash director compensation reported; transaction appears routine and unlikely to be material for valuation.
The filing shows a non-derivative award of 1,536 common shares to a director as fees with a $0 reported price, consistent with equity grants. Because the shares are unvested until 01/02/2026, immediate impact on free float and voting is constrained. There is no indication of additional transactions, sales, or option exercises by the reporting person in this filing. On its face, this disclosure does not present a material change to the issuer's capital structure.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,536 | $0.00 | $0.00 |
Footnotes (2)
- F1. Received as director fees.
- F2. Represents unvested shares received as director fees. Such shares vest on January 2, 2026, subject to earlier vesting under certain circumstances.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When was the Form 4 signed?
AI-generated analysis. How Rhea-AI works. Not financial advice.